Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Parmiani

Showing results (11-20 of 301) with videos related to

Pageof 31
Sort By:
Tumori|May 7, 2002
Vaccination with T cell-defined antigens: biological basis and clinical applicationsG Parmiani
Immunology Today|October 8, 2014
MHC class I antigens and somatic mutantsG Parmiani
Gene Therapy|November 14, 1998
Immunological approach to gene therapy of human cancer: improvements through the understanding of mechanism(s)G Parmiani
Progress in Clinical and Biological Research|January 1, 1983
Tumor antigens as modified normal cell surface antigensG Parmiani
The Keio Journal of Medicine|July 14, 2001
Melanoma antigens and their recognition by T cellsG Parmiani
Pharmacological Research|September 1, 1992
Immunotherapy of cancer with interleukin-2 and lymphocytes (LAK or TIL)G Parmiani
Nature|April 24, 1975
Tumour-associated transplantation antigens of chemically induced sarcomata cross reacting with allogeneic histocompatibility antigensG Invernizzi, G Parmiani
Tumori|March 1, 1976
In vivo inhibition of antitumor immunity by embryonic antigensR Lembo, G Parmiani
Journal of the National Cancer Institute|November 1, 1975
Nonimmunogenic sarcomas induced by 3-methylcholanthrene treatment of murine fibroblasts in diffusion chambersG Carbone, G Parmiani
Cancer Immunology, Immunotherapy : CII|September 1, 1995
Human tumor vaccines go molecular. Summary of American Association for Cancer Research Symposium, March 20,1995D Berd, G Parmiani
Pageof 31

Showing results (11-20 of 301) with videos related to

Sort By:
Pageof 31
Tumori|May 7, 2002
Vaccination with T cell-defined antigens: biological basis and clinical applicationsG Parmiani
Immunology Today|October 8, 2014
MHC class I antigens and somatic mutantsG Parmiani
Gene Therapy|November 14, 1998
Immunological approach to gene therapy of human cancer: improvements through the understanding of mechanism(s)G Parmiani
Progress in Clinical and Biological Research|January 1, 1983
Tumor antigens as modified normal cell surface antigensG Parmiani
The Keio Journal of Medicine|July 14, 2001
Melanoma antigens and their recognition by T cellsG Parmiani
Pharmacological Research|September 1, 1992
Immunotherapy of cancer with interleukin-2 and lymphocytes (LAK or TIL)G Parmiani
Nature|April 24, 1975
Tumour-associated transplantation antigens of chemically induced sarcomata cross reacting with allogeneic histocompatibility antigensG Invernizzi, G Parmiani
Tumori|March 1, 1976
In vivo inhibition of antitumor immunity by embryonic antigensR Lembo, G Parmiani
Journal of the National Cancer Institute|November 1, 1975
Nonimmunogenic sarcomas induced by 3-methylcholanthrene treatment of murine fibroblasts in diffusion chambersG Carbone, G Parmiani
Cancer Immunology, Immunotherapy : CII|September 1, 1995
Human tumor vaccines go molecular. Summary of American Association for Cancer Research Symposium, March 20,1995D Berd, G Parmiani
Pageof 31